Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Magnuson

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|January 6, 2018
Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by SubgroupsElizabeth A Magnuson, Marc P Bonaca, Deepak L Bhatt, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 29, 2021
Correspondence to European Heart Journal-Quality of Care and Clinical Outcomes in response to letter by Dalal H. et alMerrill Thomas, Philip G Jones, David J Cohen, et al.
Value in Health Regional Issues|June 27, 2017
Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese PerspectiveKatherine A Vilain, Ming Chin Yang, Elise Chia Hui Tan, et al.
Journal of the American College of Cardiology|April 22, 2017
Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main DiseaseMouin S Abdallah, Kaijun Wang, Elizabeth A Magnuson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 16, 2021
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failureMerrill Thomas, Philip G Jones, David J Cohen, et al.
Circulation|January 2, 2013
Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trialElizabeth A Magnuson, Michael E Farkouh, Valentin Fuster, et al.
Circulation|April 12, 2012
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performanceLakshmi Venkitachalam, Kaijun Wang, Avi Porath, et al.
Journal of the American College of Cardiology|July 24, 2012
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A)Matthew R Reynolds, Elizabeth A Magnuson, Kaijun Wang, et al.
Circulation. Cardiovascular Quality and Outcomes|May 17, 2017
Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)Yashashwi Pokharel, Khaja Chinnakondepalli, Katherine Vilain, et al.
Journal of the American College of Cardiology|July 29, 2017
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 TrialElizabeth A Magnuson, Haiyan Li, Kaijun Wang, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|January 6, 2018
Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by SubgroupsElizabeth A Magnuson, Marc P Bonaca, Deepak L Bhatt, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 29, 2021
Correspondence to European Heart Journal-Quality of Care and Clinical Outcomes in response to letter by Dalal H. et alMerrill Thomas, Philip G Jones, David J Cohen, et al.
Value in Health Regional Issues|June 27, 2017
Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese PerspectiveKatherine A Vilain, Ming Chin Yang, Elise Chia Hui Tan, et al.
Journal of the American College of Cardiology|April 22, 2017
Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main DiseaseMouin S Abdallah, Kaijun Wang, Elizabeth A Magnuson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 16, 2021
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failureMerrill Thomas, Philip G Jones, David J Cohen, et al.
Circulation|January 2, 2013
Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trialElizabeth A Magnuson, Michael E Farkouh, Valentin Fuster, et al.
Circulation|April 12, 2012
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performanceLakshmi Venkitachalam, Kaijun Wang, Avi Porath, et al.
Journal of the American College of Cardiology|July 24, 2012
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A)Matthew R Reynolds, Elizabeth A Magnuson, Kaijun Wang, et al.
Circulation. Cardiovascular Quality and Outcomes|May 17, 2017
Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)Yashashwi Pokharel, Khaja Chinnakondepalli, Katherine Vilain, et al.
Journal of the American College of Cardiology|July 29, 2017
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 TrialElizabeth A Magnuson, Haiyan Li, Kaijun Wang, et al.
Pageof 7